Oak Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: a choice of compounded injections, oral semaglutide and brand-name GLP-1s from one cash-pay checkout
Oak scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $100 a month; its compounded semaglutide, at $260, is 31% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
regular price $100/mo
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Prices checked October 2026
Oak is a cash-pay telehealth seller of compounded GLP-1 shots, a compounded oral semaglutide and brand-name GLP-1s. Leaf Longevity Holdings Corp. operates it as Oak Longevity, and NVP Medical Group prescribes. Compounded semaglutide lists at $250 a month and tirzepatide at $300 at the starting dose, before a checkout code. Its own FAQ says each dose step adds about $50 to $75.
Is Oak legit?
Yes. Oak is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.2/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an Oak promo or coupon code?
Oak publishes the code OAKSAVE200, which brings the price to $75 against a regular $100 a month. You enter it at checkout on Oak's own site. Other codes for Oak circulate on coupon sites, and we cannot vouch for those.
See how Oak compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Oak at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $100/mo
- What's included
- Medication · Shipping · Coaching
- Availability
- 48 states
- FDA status
- No FDA warning letters found
How Oak scores
Six columns, each one computed from something Oak has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.1/10$260/month is 31% above the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.7/10Serves 48 of 50 states.
Support10%
6.0/10The price covers the medication, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Oak
Last checked October 2026- Checked the listed price across 8 dose or plan tiers
- Checked state coverage: 48 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Oak
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Oak involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Oak shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Oak does not require a live video visit before a first prescription.
- 3Ask Oak which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $100, tirzepatide $1,200. That leaves out membership fees, first-month rates and insurance copays.
- Oak serves 48 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Oak
- Phone
- 435-244-7757
- Oak offers email support
Cancelling Oak
Taken from the terms Oak publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None (3-, 6- and 12-month plans optional)
- Refund policy
- No refunds once a provider approves the order
- Early-termination fee
- Yes
Medications Oak lists
Oak lists Wegovy, Ozempic, Zepbound, Mounjaro, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides Oak offers
Oak sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Seller's FAQ: each dose step is about $50-$75 more. 3-month supply billed upfront: $600 ($200/mo), $133/mo with the code.
Seller's FAQ: each dose step is about $50-$75 more. 3-month supply billed upfront: $801 ($267/mo), $199/mo with the code.
Listed on Oak's checkout at $100, $75 with the code. Dose not stated on the card. The $100 is below Novo Nordisk's own $149 self-pay price for the lowest Wegovy pill dose, and Oak does not say what the figure covers.
Check the price yourself before you pay
Every figure here comes from Oak's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $1,200 a month, close to the $1,299 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, shipping and coaching
- Serves 48 states
- We found no FDA warning letters issued to Oak
Against it
- Semaglutide costs $260 a month, 31% above the $199 median for compounded semaglutide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Oak charges
Oak advertises $75 as a promotional price. The regular price is $100/month, so check the offer's terms before you plan around the lower figure.
- Compounded semaglutide (injection): $200 promotional price, regular $250/month
- Compounded tirzepatide: $250 promotional price, regular $300/month
- Compounded semaglutide (oral): $245 promotional price, regular $260/month
- Wegovy tablet: $75 promotional price, regular $100/month
- Ozempic: $1,150 promotional price, regular $1,250/month
- Wegovy pen: $1,400 promotional price, regular $1,500/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Oak's $260 is a premium, and a premium has to buy something. Plan the year on the regular price, not the promotional one. Before you pay, compare Oak's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
AgelessRx dispenses semaglutide and tirzepatide from $99/month, which makes it the fair comparison to run before you commit here.
What Oak dispenses
Oak prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Oak at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Oak tells you its price before you start the medical questionnaire and the 48 states it serves. It also offers coaching as part of the plan. We found no FDA warning letters issued to Oak. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Oak will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Oak also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You would be choosing on the advertised figure. The promotional price is real, but it is not the regular price.
- You need insurance to cover the cost. Check whether Oak bills your plan before you start.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
- injections are the thing keeping you from starting
- you want coaching bundled in rather than billed on top
Our read
Oak is cheaper on its $75 promotional price than at its regular $100/month. Compare sellers at the regular price, and count the promotion as a bonus for as long as it holds.
The Bottom Line
Oak scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $100 a month; its compounded semaglutide, at $260, is 31% above the $199 median among the sellers we compare.
Before you pay Oak
Starting at $100 a month. Check today's price, then start the intake.
If you are weighing other sellers, our guide to alternatives to Oak sets more sellers in the same category beside Oak on price, states and what the price includes.
Alternatives to Oak
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Editorial score · methodology
Compare Oak head to head
Our head-to-head pages for Oak are Oak vs Gala, Oak vs Embody, Oak vs CoreAge Rx, Oak vs Direct Meds, and Oak vs SkinnyRx.
Frequently Asked Questions
How to check Oak yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: Alaska, Massachusetts, Michigan, Missouri, Montana, Oregon, Texas, Vermont and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Oak review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Oak's current pricing
Plans start at $75 a month. Whether you qualify is a clinician's decision, made after your intake.